[6] Tirzepatide (e.g., Zepbound, Mounjaro for off-label use): Also a once-weekly injectable, Tirzepatide is a unique dual agonist, meaning it mimics both GLP-1 and GIP (Glucose-dependent Insulinotropic Polypeptide)
It takes time for the semaglutide GLP-1 to absorb into your bloodstream and begin signaling your brain and digestive system
Advert She added: "In many cases, refusal is about protecting a patients long-term health and ensuring that the risks of treatment do not outweigh the benefit." If you have any of the below conditions, you should not take weight loss drugs: Digestive issues The most common side effects of these drugs are issues including nausea, vomiting, diarrhea, and constipation
PR Newswire / Eli Lilly press release (TRIUMPH-4 topline) (2025) 6
Googeer GLP-1 FAQs Q: Is this real GLP-1 or just marketing